Business Description
Sapporo Clinical Laboratory Inc
ISIN : JP3321100004
Compare
Compare
Traded in other countries / regions
9776.Japan IPO Date
1996-04-09Description
Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.77 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | 3.86 | |||||
| Interest Coverage | 79.87 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.69 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.4 | |||||
| 3-Year EBITDA Growth Rate | 11.8 | |||||
| 3-Year EPS without NRI Growth Rate | 6.2 | |||||
| 3-Year Book Growth Rate | 8.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.05 | |||||
| 9-Day RSI | 15.86 | |||||
| 14-Day RSI | 24.6 | |||||
| 6-1 Month Momentum % | 9.1 | |||||
| 12-1 Month Momentum % | -6.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.19 | |||||
| Quick Ratio | 1.99 | |||||
| Cash Ratio | 1.11 | |||||
| Days Inventory | 16.83 | |||||
| Days Sales Outstanding | 55.52 | |||||
| Days Payable | 64.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.28 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | 32 | |||||
| Forward Dividend Yield % | 4.57 | |||||
| 5-Year Yield-on-Cost % | 5.51 | |||||
| 3-Year Average Share Buyback Ratio | 0.9 | |||||
| Shareholder Yield % | 7.7 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.04 | |||||
| Operating Margin % | 3.07 | |||||
| Net Margin % | 1.96 | |||||
| FCF Margin % | 3.06 | |||||
| ROE % | 3.64 | |||||
| ROA % | 2.31 | |||||
| ROIC % | 3.84 | |||||
| ROC (Joel Greenblatt) % | 6.62 | |||||
| ROCE % | 4.41 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.52 | |||||
| PE Ratio without NRI | 7.74 | |||||
| Shiller PE Ratio | 5.27 | |||||
| PEG Ratio | 0.99 | |||||
| PS Ratio | 0.17 | |||||
| PB Ratio | 0.31 | |||||
| Price-to-Tangible-Book | 0.31 | |||||
| Price-to-Free-Cash-Flow | 5.46 | |||||
| Price-to-Operating-Cash-Flow | 2.31 | |||||
| EV-to-EBIT | 2.32 | |||||
| EV-to-EBITDA | 2.32 | |||||
| EV-to-Revenue | 0.07 | |||||
| EV-to-FCF | 2.33 | |||||
| Price-to-Projected-FCF | 0.5 | |||||
| Price-to-DCF (Earnings Based) | 0.48 | |||||
| Price-to-DCF (FCF Based) | 0.34 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Graham-Number | 0.32 | |||||
| Price-to-Net-Current-Asset-Value | 1.84 | |||||
| Earnings Yield (Greenblatt) % | 43.01 | |||||
| FCF Yield % | 19.55 | |||||
| Forward Rate of Return (Yacktman) % | 0.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sapporo Clinical Laboratory Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 19,730.284 | ||
| EPS (TTM) (円) | 116.312 | ||
| Beta | 0.22 | ||
| Volatility % | 16.82 | ||
| 14-Day RSI | 24.6 | ||
| 14-Day ATR (円) | 17.034495 | ||
| 20-Day SMA (円) | 1073.7 | ||
| 12-1 Month Momentum % | -6.83 | ||
| 52-Week Range (円) | 983 - 1200 | ||
| Shares Outstanding (Mil) | 3.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sapporo Clinical Laboratory Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sapporo Clinical Laboratory Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sapporo Clinical Laboratory Inc Frequently Asked Questions
What is Sapporo Clinical Laboratory Inc(TSE:9776)'s stock price today?
The current price of TSE:9776 is 円991.00. The 52 week high of TSE:9776 is 円1200.00 and 52 week low is 円983.00.
When is next earnings date of Sapporo Clinical Laboratory Inc(TSE:9776)?
The next earnings date of Sapporo Clinical Laboratory Inc(TSE:9776) is .
Does Sapporo Clinical Laboratory Inc(TSE:9776) pay dividends? If so, how much?
The Dividend Yield %  of Sapporo Clinical Laboratory Inc(TSE:9776) is 2.28% (As of Today), Highest Dividend Payout Ratio of Sapporo Clinical Laboratory Inc(TSE:9776) was 0.18. The lowest was 0.03. And the median was 0.06. The  Forward Dividend Yield % of Sapporo Clinical Laboratory Inc(TSE:9776) is 4.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers